Aim of the present study was to investigate possible differences between the human dopamine D4 receptor 48 bp polymorphism variants hD4.2, hD.4. and hD4.7 in agonist stimulated [35S]GTPgammaS binding, to investigate dopamine D4 receptor sodium sensitivity and to further characterize norepinephrine and epinephrine agonism at this receptor. G-protein activation at the receptor variants hD4.2, hD4.4 and hD4.7 expressed in CHO-K1 cells, following stimulation by dopamine, norepinephrine and epinephrine, was investigated using the [35S]GTPgammaS assay at experimental conditions of 10 and 100 mM sodium, respectively. Dopamine displayed a 2 fold higher potency of stimulating [35S]GTPgammaS binding at the hD4.2, compared to the hD4.4 and hD4.7 at 10 mM sodium. A significant difference in sodium sensitivity of basal [35S]GTPgammaS binding was found, with the hD4.7 being 1.7 fold more sensitive than the hD4.4 and 2.5 fold more sensitive than the hD4.2. Norepinephrine and epinephrine both produced concentration-dependent increases in [35S]GTPgammaS binding at all three receptor variants, and epinephrine showed only 2 fold less potency than dopamine. The present results are in certain line with previous reports of functional 2-3 fold differences between the dopamine D4 receptor variants. Agonism of norepinephrine and epinephrine at the dopamine D4 receptor may indicate an important way of cross-reactivity among the different monoamine neurotransmitter systems.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejphar.2005.11.063 | DOI Listing |
Anesthesiology
November 2024
Department of Anesthesiology and Perioperative Medicine, Pittsburgh Center for Pain Research, and Pittsburgh Project to End Opioid Misuse, School of Medicine, and Center for Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania.
Br J Pharmacol
April 2024
Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Spain.
Background And Purpose: Whereas biased agonism on the 5-HT receptor has been ascribed to hallucinogenic properties of psychedelics, no information about biased inverse agonism on this receptor is available. In schizophrenia, increased 5-HT receptor constitutive activity has been suggested, highlighting the therapeutic relevance of inverse agonism. This study characterized the modulation of G protein activity promoted by different drugs, commonly considered as 5-HT receptor antagonists, in post-mortem human brain cortex.
View Article and Find Full Text PDFPediatr Res
June 2024
Biomedical Research Foundation, Hospital Clínico San Calos-IdISSC, Madrid, Spain.
Background: Neonatal rats can manifest post-stroke mood disorders (PSMD) following middle cerebral artery occlusion (MCAO). We investigated whether cannabidiol (CBD) neuroprotection, previously demonstrated in neonatal rats after MCAO, includes prevention of PSMD development.
Methods: Seven-day-old Wistar rats (P7) underwent MCAO and received either vehicle or 5 mg/kg CBD treatment.
Methods Mol Biol
July 2023
Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain.
Heterotrimeric guanine nucleotide-binding proteins (G proteins) are the very first effector in signal transduction events triggered by G-protein-coupled receptors (GPCRs). One of the most widely used approaches for determining GPCR activity in native tissue is based on the binding of [S]GTPγS. Classically, an heterogeneous procedure including a filtration step has been used, but a modification of the protocol including an immunoprecipitation step has allowed the specific discrimination of the contribution of the different Gα subunit subtypes to the effect of each ligand.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!